drugset / Trial / NCT01265147
Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal Carcinoma
Phase 2
Unknown
20 enrolled
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This phase II trial is studying cisplatin or nedaplatin combine with IMRT to evaluate which one is better efficacy and security in nasopharyngeal carcinoma.
Timeline
- Start
- 2011-01
- Primary completion
- 2012-12
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cisplatin | Other / unclassified | 40 mg/m2 | — |
| Subject | Nedaplatin | Small molecule | 40 mg/m2 | — |